These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12536905)

  • 41. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
    Suzuki K; Morita T; Tokue A
    Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients.
    Cheng L; Pan CX; Yang XJ; Lopez-Beltran A; MacLennan GT; Lin H; Kuzel TM; Papavero V; Tretiakova M; Nigro K; Koch MO; Eble JN
    Cancer; 2004 Sep; 101(5):957-62. PubMed ID: 15329903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Synthesis on the treatments of infiltrating tumors of the bladder].
    Bouchot O; Zerbib M
    Prog Urol; 2002 Nov; 12(5):1143-57. PubMed ID: 12536939
    [No Abstract]   [Full Text] [Related]  

  • 44. Staging of the urinary bladder tumors.
    Kchir N; Mekni A; Zitouna Kh; Bellil K; Bellil S; Haouet S
    Tunis Med; 2005 Dec; 83 Suppl 12():24-5. PubMed ID: 16430062
    [No Abstract]   [Full Text] [Related]  

  • 45. Clonal origin of lymph node metastases in bladder carcinoma.
    Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
    Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridization.
    Matsubara H; Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Honda N
    Oncol Rep; 2008 Jan; 19(1):57-63. PubMed ID: 18097576
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Definition of specific protein patterns for advanced (metastatic) urinary bladder tumors for individual prognosis determination and treatment choice].
    Junker K; Pilchowski R; Stöhr R; von Eggeling F; Schubert J; Hartmann A
    Urologe A; 2007 Sep; 46(9):1288. PubMed ID: 17593341
    [No Abstract]   [Full Text] [Related]  

  • 48. [Determination of grade of urothelial carcinoma according to WHO 2004 classification].
    Kruslin B; Belicza M
    Lijec Vjesn; 2006; 128(7-8):201-6. PubMed ID: 17087133
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Editorial comment on: Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light.
    Lerner SP
    Eur Urol; 2007 Dec; 52(6):1708-9. PubMed ID: 17646045
    [No Abstract]   [Full Text] [Related]  

  • 50. [TNM classification--bladder cancer].
    Takayasu H
    Gan No Rinsho; 1967 May; 13(5):316-9. PubMed ID: 5624084
    [No Abstract]   [Full Text] [Related]  

  • 51. [Characteristics of a new bladder cancer classification].
    Altarac S
    Lijec Vjesn; 2006; 128(9-10):322. PubMed ID: 17128672
    [No Abstract]   [Full Text] [Related]  

  • 52. How wide is the spectrum of neuroendocrine carcinoma of the urinary bladder?
    Vakar-Lopez F; True LD
    Am J Clin Pathol; 2007 Nov; 128(5):723-5. PubMed ID: 17951191
    [No Abstract]   [Full Text] [Related]  

  • 53. [Histologic prognosis of infiltrating urothelial tumors].
    Renaudin K; Moreau A; Buzelin F
    Prog Urol; 2002 Nov; 12(5):803-4. PubMed ID: 12536908
    [No Abstract]   [Full Text] [Related]  

  • 54. [Infiltrating bladder tumours].
    Lebret T
    Rev Prat; 2007 Mar; 57(6):630-40. PubMed ID: 17593787
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lymphadenectomy for invasive bladder cancer. II. technical aspects and prognostic factors.
    Stein JP; Quek ML; Skinner DG
    BJU Int; 2006 Feb; 97(2):232-7. PubMed ID: 16430619
    [No Abstract]   [Full Text] [Related]  

  • 56. Classification of canine urinary bladder urothelial tumours based on the World Health Organization/International Society of Urological Pathology consensus classification.
    Patrick DJ; Fitzgerald SD; Sesterhenn IA; Davis CJ; Kiupel M
    J Comp Pathol; 2006 Nov; 135(4):190-9. PubMed ID: 17054974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. When is a negative lymph node really negative? Molecular tools for the detection of lymph node metastasis from urological cancer.
    Theodorescu D; Frierson HF
    Urol Oncol; 2004; 22(3):256-9. PubMed ID: 15271328
    [No Abstract]   [Full Text] [Related]  

  • 58. Bladder carcinoma and a TNM system of classification.
    Prout GR
    J Urol; 1977 May; 117(5):583-90. PubMed ID: 859200
    [No Abstract]   [Full Text] [Related]  

  • 59. Editorial comment on: Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder.
    Lotan Y
    Eur Urol; 2008 Mar; 53(3):579-80. PubMed ID: 17804152
    [No Abstract]   [Full Text] [Related]  

  • 60. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients.
    Montie JE
    J Urol; 2005 Jun; 173(6):1920-1. PubMed ID: 15879778
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.